Liposarcomas (LPS) account for approximately 15% of all sarcomas among mesenchymal neoplasms and 6% of primary mediastinal tumors. LPS, usually found in the lower extremities or retroperitoneum, have also been reported in the abdomen, vulva, and buttocks. However, primary LPS of the anterior mediastinum are extremely rare. In this paper, we present a case of a fast progressing metastatic primary myxoid liposarcoma of the anterior mediastinum.
INTRODUCTION
Liposarcomas (LPS) account for approximately 15% of all sarcomas among mesenchymal neoplasms and comprise 6% of primary mediastinal tumors (1) (2) (3) . LPS are generally found in the lower extremities or retroperitoneum, but they have also been reported in the abdomen, vulva, and buttocks. However, primary LPS of the anterior mediastinum are extremely rare (2) . Myxoid LPS composed of round cells with differing lipoblastic differentiation in an abundantly myxoid vascular background is the second most prevalent subtype of liposarcoma (4, 5) . Surgery remains the primary therapeutic modality. Different pathological subtypes may present with different epidemiological features and biological behaviors. Recent advances in genetic characterization of LPS indicate four histogenetic types. These are well-differentiated/dedifferentiated, myxoid, pleomorphic, and unclassified liposarcoma (6) . An important prognostic factor is the pathological subtype determined. We present a fast progressing metastatic primary myxoid liposarcoma of the anterior mediastinum, which resulted in an exitus within nine months and discuss its clinical, imaging, and pathological aspects by reviewing relevant current literature. Written informed consent was obtained from a first-degree relative of the patient.
CASE PRESENTATION
A 46-year-old non-smoking female patient presented to our outpatient department with mild chest and back pain. She reported no shortness of breath or weight loss. She had no significant medical or family history. Her physical examination and laboratory results were unremarkable. Her chest X-ray showed an upper mediastinal enlargement on the right paratracheal area, and her chest computed tomography (CT) scan confirmed a mediastinal mass of 80 × 50 mm located in the right upper anterior mediastinum (Figure 1, 2) . The mass had a necrotic center and an invasion into the superior vena cava and brachiocephalic trunk. An ultrasound-guided fine needle aspiration was performed from the tumor.
The pathological study revealed myxoid stroma and a visible rich vascular structure with thin branches, vacuolated cytoplasm, pleomorphic lipoblast type cells, and mitotic figures with atypical cells. Immunohistochemical analysis with Vimentin and S-100 showed positive staining ( Figure 3 ). The final pathological diagnosis was myxoid liposarcoma.
After the pathological diagnosis, positron emission tomography (PET)/CT scan was performed, displaying a mass of 77 × 60 × 71 mm of heterogeneous character and soft tissue density with a standardized uptake value of a maximum of 4.49. There were no other pathological findings.
Surgical intervention was ruled out because the mass had a necrotic center and invasion into the superior vena cava and brachiocephalic trunk. In line with the decision of the Oncology Board, chemoradiotherapy was considered the most appropriate treatment modality.
Because chemotherapy would increase the effectiveness of radiotherapy, the patient underwent concomitant chemotherapy and radiotherapy. She received standard doses of chemotherapy, including adriamycin (60 mg/m²) and ifosfamide (2.5 g/m²) in two cycles. Radiotherapy was performed after calculation of the dosage using the intensity-modulated radiation therapy (IMRT) technique daily at 200 cGy per fraction in 25 fractions to a total dose of 5000 cGy applied externally to the approximately 8 cm mass in the mediastinum. Six weeks after the radiotherapy, a CT scan was performed (Figure 4 ). The CT scan revealed neither shrinkage nor further progression after the treatment. Based on the outcome, she was regarded as a stable patient without any partial or complete response, showing neither a decline nor an increase in the tumor size. She broke her appointments for monthly control even though she was urged not to do so. She instead sought alternative herbal treatment for five months before she showed up again; however, by then, she already had distant liver metastasis (Figure 5) . The chest CT scan showed multiple metastases in both lobes, the largest one measuring 43 × 38 mm in the left lobe of the liver. . Despite treatment for liver metastasis, the patient showed a rapid progression ( Figure 6 ). The number and size of the metastases rapidly increased in both lobes, the largest one measuring approximately 8 cm. The patient died three months after the detection of the liver metastasis.
DISCUSSION
LPS usually occur in the deep soft tissues of the lower extremities and retroperitoneum and are seldom found in the mediastinum (3). Boland et al. (6) studied 24 cases. According to the clinicopathological analysis made by Hahn and Fletcher (7), among the 24 patients, only two were categorized as myxoid liposarcoma, whereas nine had liposarcoma in the anterior mediastinum. Liposarcoma in the mediastinum is rarely seen. In Turkey, till date, there are three reported mediastinal liposarcoma cases that were reported by Yekeler et al. (8), Düzgün et al. (9) and Ağca et al. (10) . Similarly, cases with anterior mediastinal liposarcoma are rare worldwide, according to the relevant literature (11) , which led us to report the present case. In a review by Schweitzer et al. (12) , 63% of patients presented with respiratory symptoms, 50% with chest pain, and 15% with superior vena cava obstruction. The presenting symptoms included chest pain, dyspnea, cough, and superior vena cava syndrome, which were associated with compression to the adjacent organs. Commonly, such patients tend to be asymptomatic, and most of them are diagnosed by routine chest X-rays that show mass shadows (3) . In the present case, our patient had an insignificant chest and back pain for the last three months before the diagnosis was made. There were no other symptoms. The routine X-ray chest image revealed a mass on the right upper zone. Because of this, the patient underwent further diagnostic intervention. Liposarcoma of the anterior mediastinum is usually removed by total resection. Although there is a general tendency to manage mediastinal liposarcoma with surgery, it was inappropriate because of the invasion of two major mediastinal vessels in the current case, and chemoradiotherapy was preferred.
Principles of treatment include surgical resection and adjuvant radiochemotherapy. Despite multimodality therapy, the prognosis continues to be poor (2,13).
Myxoid liposarcoma is most often composed of bland round cells with variable lipoblastic differentiation scattered in an abundantly myxoid, highly vascular background. Rarely, a myxoid liposarcoma shows extensive mature adipocytic differentiation (differentiated myxoid liposarcoma). High grade myxoid liposarcoma (round cell liposarcoma) shows markedly increased cellularity, elevated nuclear grade, high mitotic activity, and loss of myxoid matrix. In the present case, there might as well have been a vascular invasion. In this case, the mass had a necrotic center and an invasion into the superior vena cava and brachiocephalic trunk. The present findings ruled out surgical intervention. In line with the decision of the Oncology Board, chemoradiotherapy was considered as the most appropriate treatment modality. No shrinkage was observed in the tumor size as a result of chemotherapy. Initially, the patient was considered as stable, showing neither a decline nor an increase in the tumor size. However, she developed distant liver metastasis after five months, resulting in an exitus within nine months after the diagnosis of mediastinal LPS. Mediastinal liposarcoma is a rare disease. Surgery is the primary therapeutic modality. Different pathological subtypes may present with different epidemiological features and biological behaviors. An important prognostic factor is the pathological subtype determined. Well-differentiated tumors can have a better prognosis compared with other subtypes. Despite multimodality therapy, as in the present case, the prognosis continues to be poor unless there is surgical intervention (13) . As stated by Boland et al. (6) , patients with myxoid liposarcoma, like in our case, have a faster disease progression with a fatal outcome.
CONCLUSION
Myxoid mediastinal liposarcoma is a rare tumor with a good prognosis if it can be surgically removed. The progression is quite fast with a significantly higher mortality rate in cases without surgical intervention. Hence, these patients have to undergo surgical intervention as quickly as possible. 
